SCHEMBL14690128

SCHEMBL14690128

O=C(/C=C/C(=O)OF)OF

nearest known ligand 0.44

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 7/20 0.44
KEAP1 Q14145 1/20 0.44
NFE2L2 Q16236 1/20 0.44
ATM Q13315 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1252113 1.00 HCAR2 (0.44) HCAR2KEAP1NFE2L2ATM
SCHEMBL27934007 0.87
SCHEMBL11223859 0.83
SCHEMBL27480835 0.81
SCHEMBL27520850 0.81
SCHEMBL28179973 0.81 KEAP1 (0.32) HCAR2KEAP1NFE2L2
SCHEMBL8900190 0.76
SCHEMBL27306780 0.76
SCHEMBL27477995 0.74
SCHEMBL425800 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103483194-A 2-fuloro fumarate (formula I), and preparation method and application thereof YANG YINKE 2014-01-01 CN claimed
CN-106030309-B Universal antigen retrieval compounds and methods of use thereof 休斯敦大学系统 2019-11-26 CN disclosed
CN-106030309-A Universal antigen retrieval compounds and methods of use thereof 休斯敦大学系统 2016-10-12 CN disclosed
CN-103483194-B A kind of 2-fluoro fumarate (structural formula I) and preparation method thereof and application YANG YINKE (CN) 2016-03-09 CN disclosed
US-20150196585-A1 COMPOSITIONS COMPRISING CROSSLINKED CATION-BINDING POLYMERS AND USES THEREOF VIFOR (INTERNATIONAL) LTD. (CH) 2015-07-16 US disclosed
US-20150183908-A1 COMPOSITIONS COMPRISING CROSSLINKED CATION-BINDING POLYMERS AND USES THEREOF VIFOR (INTERNATIONAL) LTD. (CH) 2015-07-02 US disclosed
EP-2874633-A1 COMPOSITIONS COMPRISING CROSSLINKED CATION-BINDING POLYMERS Relypsa, Inc. (US) 2015-05-27 EP disclosed
US-8884093-B2 Method of treating effluents containing halogenated compounds CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) 2014-11-11 US disclosed
WO-2014015240-A1 COMPOSITIONS COMPRISING CROSSLINKED CATION-BINDING POLYMERS SORBENT THERAPEUTICS, INC. (US) 2014-01-23 WO disclosed
WO-2014015244-A1 COMPOSITIONS COMPRISING CROSSLINKED CATION-BINDING POLYMERS SORBENT THERAPEUTICS, INC. (US) 2014-01-23 WO disclosed
CN-103483194-A 2-fuloro fumarate (formula I), and preparation method and application thereof YANG YINKE 2014-01-01 CN disclosed
US-20130041200-A1 METHOD OF TREATING EFFLUENTS CONTAINING HALOGENATED COMPOUNDS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) 2013-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150183908-A1 COMPOSITIONS COMPRISING CROSSLINKED CATION-BINDING POLYMERS AND USES THEREOF PICALM, ORAI1, KCNN3 HCAR2 471/4885KEAP1 3452/4885NFE2L2 4531/4885
US-20150196585-A1 COMPOSITIONS COMPRISING CROSSLINKED CATION-BINDING POLYMERS AND USES THEREOF SSB, PARG, HLA-DRB1 HCAR2 978/4885KEAP1 2029/4885NFE2L2 3682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.